Eli Lilly and Company’s executive vice president and chief information and digital officer, Diogo Rau, has highlighted the dual benefits of reducing the use of paper inserts in pharmaceutical packaging. Speaking in a recent interview, Rau noted that cutting down on the estimated 90 billion sheets of paper used annually for medicine inserts not only supports environmental sustainability but also improves accessibility for patients facing vision impairments, language barriers, or cognitive and physical disabilities.
Rau emphasized that transitioning away from traditional paper inserts addresses significant challenges for individuals who may struggle to access critical drug information due to these limitations. By adopting alternative methods of communication, such as digital formats or other accessible solutions, pharmaceutical companies can ensure that all patients receive the necessary information about their medications. This approach aligns with broader efforts within the industry to enhance inclusivity while simultaneously reducing environmental impact.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
Date: September 3, 2025
發佈留言